Qube Research & Technologies LTD Scholar Rock Holding Corp Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.84 - $16.79 $1.5 Million - $3.22 Million	191,788 Added 574.96%	225,145 $1.88 Million
Q1 2024 May 14, 2024	BUY	$13.2 - $17.76 $363,382 - $488,915	27,529 Added 472.36%	33,357 $592,000
Q4 2023 Feb 13, 2024	BUY	$6.52 - $20.32 $37,998 - $118,424	5,828 New	5,828 $109,000
Q1 2023 May 15, 2023	BUY	$7.36 - $12.72 $344,455 - $595,308	46,801 Added 87.79%	100,114 $800,000
Q4 2022 Feb 14, 2023	BUY	$7.02 - $9.76 $252,467 - $351,008	35,964 Added 207.3%	53,313 $482,000
Q3 2022 Nov 14, 2022	SELL	$5.33 - $11.3 $11,843 - $25,108	-2,222 Reduced 11.35%	17,349 $120,000
Q2 2022 Aug 15, 2022	SELL	$4.66 - $13.96 $42,424 - $127,091	-9,104 Reduced 31.75%	19,571 $107,000
Q1 2022 May 09, 2022	BUY	$11.89 - $24.68 $340,945 - $707,699	28,675 New	28,675 $370,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.